Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
BMC Urology
(ISSN: 1471-2490)
This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.
How common is the problem of non-adherence among patients prescribed drug therapy for BPH-associated LUTS? Find out how the pattern varies between drug classes.
What does the latest research tell us about the safety of intravesical instillation of cytotoxic chemotherapy in patients undergoing nephroureterectomy?
How is patient health-related quality of life impacted after these therapies for prostate cancer, and how does it compare between the treatment options?
Learn more about the therapeutic options available for invasive bladder cancer -- and which patient characteristics may influence treatment decisions for this advanced disease.
Mission Statement:
BMC Urology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of urological disorders, as well as related molecular genetics, pathophysiology, and epidemiology.